top of page

United Kingdom’s withdrawal from the European Union: Regulatory preparedness and Decision on EMA&#3

On 29 March 2017, the United Kingdom (UK) notified the European Council of its intention to withdraw from the European Union (EU). The implications of Brexit for the European Medicines Agency's (EMA) location and operations depend on the future relationship between the UK and the EU, which is unknown at present.


#PharmaNews #RegulatoryAffairsHuman #LegislationPharmacovigilance

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page